Multifunctional role CD36 in progressive renal fibrosis
CD36在进行性肾纤维化中的多功能作用
基本信息
- 批准号:7637999
- 负责人:
- 金额:$ 12.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-nitrotyrosineAcuteAdvanced Glycosylation End ProductsAffectAmino AcidsAmyloidAnimal ModelApoptosisApoptoticArchitectureAtherosclerosisAttenuatedAwardBiologicalBiological ModelsBiologyBone MarrowCD36 geneCell LineCellsChronicChronic Kidney FailureCollaborationsCommunitiesDataDevelopmentDisease ProgressionDistalEnd stage renal failureEndocytosisEnvironmentEpithelial CellsEtiologyEventExtracellular MatrixFamilyFatty AcidsFibrosisFoundationsGelGoalsHealthIn VitroInflammationInjuryK-Series Research Career ProgramsKidneyKidney DiseasesLaboratoriesLeadLigandsLipoproteinsMacrophage ActivationMalariaMarrowMass Spectrum AnalysisMediatingMentorsMentorshipModelingMolecular BiologyMusNF-kappa BNitratesObstructionOxidantsOxidative StressOxidative Stress PathwayPathway interactionsPatientsPhospholipidsPlayPost-Translational Protein ProcessingProcessProductionProteinsProteomicsReactive Oxygen SpeciesRenal functionRenal tubule structureResearchResearch PersonnelRoleSR-B proteinsSeveritiesSignal PathwayTherapeuticTimeTissuesTrainingTransforming Growth Factor betaTransgenic OrganismsTransplantationTubular formationUnited StatesUniversitiesUreteral obstructionWashingtonWild Type MouseWorkangiogenesisatherogenesiscareercell typefibrogenesisimprovedin vitro Modelin vivomacrophagenitrationnoveloxidationoxidized low density lipoproteinprogramsreceptorreceptor functionresearch studyresponsescavenger receptortherapeutic targettool
项目摘要
DESCRIPTION (provided by applicant):
The purpose of this application is to further define key pathways in kidney fibrosis, particularly the functional relationship between ligands and their receptor in the progression of fibrosis. Our preliminary data supports the hypothesis that the scavenger receptor CD36 mediates the proinflammatory and profibrotic effects of thrombospondin and oxidized lipoproteins during progressive renal fibrosis. In response to chronic injury induced by obstruction, CD36 mediates important fibrogenic responses, as the severity of renal fibrosis is significantly attenuated in CD36 deficient mice and is associated with decreased NF-kappa B activation and oxidative stress despite higher levels thrombospondin and nitrotyrosine, a marker of protein oxidation, in the tubulointerstitium. The first aim is to elucidate the profibrotic relationship between CD36 and thrombospondin and oxidized lipoproteins in an animal model of chronic renal fibrosis by: (1) investigating the thrombospondin-CD36 relationship in TGF-beta activation and angiogenesis; and (2) diffentiating oxidant pathways and targets of oxidized protein modification modulated by CD36 through mass spectrometry and 2-D protein gel analysis. The second aim is to differentiate macrophage and renal tubular cell dependent effects of CD36 in fibrogenesis using chimeric mouse strategies. The third aim is to investigate in vitro mechanisms whereby tubular CD36 modulates intracellular oxidation pathways during fibrosis. By improving our understanding of the key cellular receptors and the pathways they mediate in the progression of renal fibrosis, these studies will help to identify potential therapeutic targets for chronic kidney disease (CKD) with the goal of developing novel therapies to halt or slow the progression of CKD and alleviate the tremendous health burden of end-stage renal disease. This research will prepare the applicant for an academic career as an independent investigator in the field of kidney fibrogenesis. He will obtain further training in molecular biology, biological mass spectrometry analysis, develop in vitro model systems and gain expertise in the field of renal fibrosis. The transition to independence will be facilitated by the rich environment provided under the mentorship of Dr. Allison Eddy and collaborations with Drs. Jay Heinecke and Maria Febbraio, and by joining a large community of productive researchers focusing on the pathobiology of renal disease at the University of Washington.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DARYL Miyoshi OKAMURA其他文献
DARYL Miyoshi OKAMURA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DARYL Miyoshi OKAMURA', 18)}}的其他基金
Uncovering CD36-mediated oxidative and inflammatory pathways in progressive renal
揭示进行性肾病中 CD36 介导的氧化和炎症途径
- 批准号:
7638229 - 财政年份:2009
- 资助金额:
$ 12.83万 - 项目类别:
Uncovering CD36-mediated oxidative and inflammatory pathways in progressive renal
揭示进行性肾病中 CD36 介导的氧化和炎症途径
- 批准号:
7919307 - 财政年份:2009
- 资助金额:
$ 12.83万 - 项目类别:
Multifunctional role CD36 in progressive renal fibrosis
CD36在进行性肾纤维化中的多功能作用
- 批准号:
7148352 - 财政年份:2006
- 资助金额:
$ 12.83万 - 项目类别:
Multifunctional role CD36 in progressive renal fibrosis
CD36在进行性肾纤维化中的多功能作用
- 批准号:
7446765 - 财政年份:2006
- 资助金额:
$ 12.83万 - 项目类别:
Multifunctional role CD36 in progressive renal fibrosis
CD36在进行性肾纤维化中的多功能作用
- 批准号:
7255782 - 财政年份:2006
- 资助金额:
$ 12.83万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 12.83万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 12.83万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 12.83万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 12.83万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 12.83万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 12.83万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 12.83万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 12.83万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 12.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 12.83万 - 项目类别:
Standard Grant














{{item.name}}会员




